Non-invasive glucose monitoring remains a critical challenge in the management of diabetes. HRV during sleep shows promise for glucose prediction however, age-related autonomic changes significantly confound traditional HRV analyses. We analyzed 43 subjects with multi-modal data including sleep-stage specific ECG, HRV features, and clinical measurements. A novel age-normalization technique was applied to the HRV features by, dividing the raw values by age-scaled factors. BayesianRidge regression with 5-fold cross-validation was employed for log-glucose prediction. Age-normalized HRV features achieved R2 = 0.161 (MAE = 0.182) for log-glucose prediction, representing a 25.6% improvement over non-normalized features (R2 = 0.132). The top predictive features were hrv rem mean rr age normalized (r = 0.443, p = 0.004), hrv ds mean rr age normalized (r = 0.438, p = 0.005), and diastolic blood pressure (r = 0.437, p = 0.005). Systematic ablation studies confirmed age-normalization as the critical component, with sleep-stage specific features providing additional predictive value. Age-normalized HRV features significantly enhance glucose prediction accuracy compared with traditional approaches. This sleep-aware methodology addresses fundamental limitations in autonomic function assessment and suggests a preliminary feasibility for non-invasive glucose monitoring applications. However, these results require validation in larger cohorts before clinical consideration.